Trial intelligence / Profile preview

Remimazolam vs propofol for postoperative delirium in frail elderly hip surgery patients

ChiCTR2300068632Phase 4Recruiting

Sponsor
Zhongda Hospital, Southeast University
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative delirium (POD) comparing Remimazolam arm with Propofol arm (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Mar 2023; status: recruiting.

02

Drugs

remimazolampropofol
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2300068632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300068632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call